查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594331

分子品管市场：按产品类型、分析物类型、应用、最终用户 - 2025-2030 年全球预测

Molecular Quality Controls Market by Product (Independent Controls, Instrument-Specific Controls), Analyte Type (Multi-Analyte Controls, Single-Analyte Controls), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年分子品管市场价值为2.0125亿美元，预计到2024年将达到2.1787亿美元，复合年增长率为8.74%，到2030年将达到3.6187亿美元。

分子品管对于确保在临床实验室中发挥关键作用的分子诊断测试的准确性和可靠性至关重要。这些控制对于检验诊断分析的性能、实验室之间的基准一致性以及支援监管机构的认证要求是必要的。其应用范围广泛，包括传染病检查、癌症诊断、基因检测、个人化医疗等，在临床实验室、研究机构和医院中不可或缺。推动市场的主要成长要素包括分子诊断的技术进步、感染疾病病率的增加以及个人化医疗的日益采用。对医疗保健领域监管合规性和品质保证的日益关注进一步推动了需求。由于医疗投资的增加和检测能力的扩大，新兴市场提供了商机。然而，品管产品高成本、发展中地区意识淡薄以及严格的监管环境等挑战可能会阻碍成长。公司可以透过创新具有成本效益的解决方案并透过策略联盟和培训计划提高知名度来抓住机会。在开发与自动化平台相容的整合控制解决方案、增加復用能力以及提高控制稳定性和保质期方面存在巨大的创新潜力。此外，透过开发可客製化的、针对特异性疾病的品管方法，我们可以更好地满足市场需求。市场竞争激烈，整合趋势透过策略併购提供了成长机会。参与企业必须确保适应不断发展的技术和监管环境，以保持竞争力。此外，我们可以透过与诊断公司合作提供量身定制的解决方案来扩大我们的影响力和影响力。加快对新型生物标记和数位平台的研究将支持提高竞争力和诊断准确性的总体目标。在这些动态的作用下，利用技术进步和对当地市场需求的敏锐了解的敏捷方法可能会导致该市场的业务成功。

主要市场统计
基准年[2023] 20125万美元
预测年份 [2024] 21787万美元
预测年份 [2030] 36187万美元
复合年增长率（%） 8.74%

市场动态：揭示快速发展的分子品管市场的关键市场洞察

分子品管市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病高发生率和疾病检测的必要性
    • 基因组学的政府津贴和资助
    • 临床实验室数量增加，多项目检测需求增加
  • 市场限制因素
    • 不利的报销情况和品管的额外成本
  • 市场机会
    • 对个人化医疗和第三方品管的日益偏好
    • 随着分子测试的发展，可能性越来越大
  • 市场挑战
    • 品管物资匮乏，检测系统定量产出，新的基因检测标靶每天层出不穷

波特五力：驾驭分子品管市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解分子品管市场的外部影响

外部宏观环境因素在塑造分子品管市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解分子品管市场的竞争格局

对分子品管市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵分子品管市场供应商绩效评估

FPNV 定位矩阵是评估分子品管市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了分子品管市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，分子品管市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病的传播和检测的必要性
      • 基因组学的政府津贴和资助
      • 临床实验室数量增加，多专案检测管理需求增加
    • 抑制因素
      • 不利的报销情况和品管的额外成本
    • 机会
      • 对个人化医疗和第三方品管的兴趣日益浓厚
      • 随着分子测试的发展，机会也在增加
    • 任务
      • 缺乏品管材料、定量检测系统输出，新的基因检测标靶每天都在出现
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章分子品管市场：副产品

  • 独立控制
  • 仪器特定控制

第七章依分析物类型分類的分子品管市场

  • 多分析物控制
  • 单一分析物对照

第八章分子品管市场：依应用分类

  • 基因检测
  • 感染疾病
  • 肿瘤学

第九章分子品管市场：按最终用户

  • 学术研究所
  • 临床实验室
  • 医院
  • IVD 製造商和合约研究机构

第十章美洲分子品管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太分子品管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的分子品管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Anchor Molecular Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Fortress Diagnostics
  • Grifols SA
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Microbix Biosystems Inc.
  • Qnostics Ltd.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Seegene, Inc.
  • SpeeDx Pty Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5A2C6AA667CA

The Molecular Quality Controls Market was valued at USD 201.25 million in 2023, expected to reach USD 217.87 million in 2024, and is projected to grow at a CAGR of 8.74%, to USD 361.87 million by 2030.

Molecular Quality Controls are essential in ensuring the accuracy and reliability of molecular diagnostic tests, which play a critical role in clinical laboratory settings. These controls are necessary for validating the performance of diagnostic assays, benchmarking inter-laboratory consistency, and supporting accreditation requirements by regulatory bodies. Their applications span infectious disease testing, cancer diagnostics, genetic testing, and personalized medicine, making them indispensable in clinical laboratories, research institutions, and hospitals. Key growth factors driving the market include technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, and the increasing adoption of personalized medicine. The growing focus on regulatory compliance and quality assurance in healthcare further fuels demand. Emerging markets present opportunities due to heightened healthcare investments and expanding testing capacities. However, challenges such as the high cost of quality control products, limited awareness in developing regions, and stringent regulatory landscapes may hinder growth. Companies can capitalize on opportunities by innovating cost-effective solutions and increasing awareness through strategic collaborations and training programs. There is immense potential for innovation in developing integrated control solutions compatible with automated platforms, enhancing multiplexing capabilities, and improving the stability and shelf life of controls. Moreover, creating customizable and disease-specific quality controls can meet precise market needs. The nature of the market is competitive, with consolidation trends presenting opportunities for growth through strategic mergers and acquisitions. Entrants must ensure adaptability to evolving technological and regulatory landscapes to maintain competitiveness. Furthermore, collaborating with diagnostic companies to provide tailor-made solutions could also expand reach and influence. Fostering research into novel biomarkers and digital platforms could provide a competitive edge and support the overarching goal of boosting diagnostic accuracy. Amid these dynamics, a keen understanding of regional market demands and an agile approach to leveraging technological advancements will help businesses thrive in this market.

KEY MARKET STATISTICS
Base Year [2023] USD 201.25 million
Estimated Year [2024] USD 217.87 million
Forecast Year [2030] USD 361.87 million
CAGR (%) 8.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Quality Controls Market

The Molecular Quality Controls Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of infectious diseases and need for diseases testing
    • Government grants and funding for genomics
    • Increase in number of clinical laboratories and rising demand for multi-analyte controls
  • Market Restraints
    • Unfavorable reimbursement scenario and additional costs for quality control
  • Market Opportunities
    • Rising preferences for personalized medicine and third-party quality controls
    • Increasing potential with evolving landscape of molecular testing
  • Market Challenges
    • Lack of quality control materials, quantitative test system outputs, and the daily appearance of new genetic test targets

Porter's Five Forces: A Strategic Tool for Navigating the Molecular Quality Controls Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Quality Controls Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Molecular Quality Controls Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Quality Controls Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Molecular Quality Controls Market

A detailed market share analysis in the Molecular Quality Controls Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Quality Controls Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Quality Controls Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Quality Controls Market

A strategic analysis of the Molecular Quality Controls Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Molecular Quality Controls Market, highlighting leading vendors and their innovative profiles. These include Anchor Molecular Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Fortress Diagnostics, Grifols S.A., LGC Limited, Maine Molecular Quality Controls, Inc., Microbiologics, Inc., Microbix Biosystems Inc., Qnostics Ltd., Quidel Corporation, Randox Laboratories Ltd., Seegene, Inc., SpeeDx Pty Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Molecular Quality Controls Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Independent Controls and Instrument-Specific Controls.
  • Based on Analyte Type, market is studied across Multi-Analyte Controls and Single-Analyte Controls.
  • Based on Application, market is studied across Genetic Testing, Infectious Diseases, and Oncology.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Laboratories, Hospitals, and IVD Manufacturers & Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of infectious diseases and need for diseases testing
      • 5.1.1.2. Government grants and funding for genomics
      • 5.1.1.3. Increase in number of clinical laboratories and rising demand for multi-analyte controls
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement scenario and additional costs for quality control
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preferences for personalized medicine and third-party quality controls
      • 5.1.3.2. Increasing potential with evolving landscape of molecular testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of quality control materials, quantitative test system outputs, and the daily appearance of new genetic test targets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Molecular Quality Controls Market, by Product

  • 6.1. Introduction
  • 6.2. Independent Controls
  • 6.3. Instrument-Specific Controls

7. Molecular Quality Controls Market, by Analyte Type

  • 7.1. Introduction
  • 7.2. Multi-Analyte Controls
  • 7.3. Single-Analyte Controls

8. Molecular Quality Controls Market, by Application

  • 8.1. Introduction
  • 8.2. Genetic Testing
  • 8.3. Infectious Diseases
  • 8.4. Oncology

9. Molecular Quality Controls Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Laboratories
  • 9.4. Hospitals
  • 9.5. IVD Manufacturers & Contract Research Organizations

10. Americas Molecular Quality Controls Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Molecular Quality Controls Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Molecular Quality Controls Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anchor Molecular Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Bio-Techne Corporation
  • 4. Fortress Diagnostics
  • 5. Grifols S.A.
  • 6. LGC Limited
  • 7. Maine Molecular Quality Controls, Inc.
  • 8. Microbiologics, Inc.
  • 9. Microbix Biosystems Inc.
  • 10. Qnostics Ltd.
  • 11. Quidel Corporation
  • 12. Randox Laboratories Ltd.
  • 13. Seegene, Inc.
  • 14. SpeeDx Pty Ltd.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MOLECULAR QUALITY CONTROLS MARKET RESEARCH PROCESS
  • FIGURE 2. MOLECULAR QUALITY CONTROLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MOLECULAR QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MOLECULAR QUALITY CONTROLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOLECULAR QUALITY CONTROLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOLECULAR QUALITY CONTROLS MARKET DYNAMICS
  • TABLE 7. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INDEPENDENT CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY MULTI-ANALYTE CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY SINGLE-ANALYTE CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY IVD MANUFACTURERS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. MOLECULAR QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. MOLECULAR QUALITY CONTROLS MARKET, FPNV POSITIONING MATRIX, 2023